Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI

NeuroImage

Volumn 59, Issue 3, 2012, Pages 2743-2750

  Fernández Seara, María A ^a   Mengual, Elisa ^a,b   Vidorreta, Marta ^a   Aznárez Sanado, Maite ^a   Loayza, Francis R ^a   Villagra, Federico ^a   Irigoyen, Jaione ^a   Pastor, María A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Arterial spin labeling; Global mean normalization; Parkinson's disease; Perfusion

Indexed keywords

AMANTADINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN PERFUSION; CAUDATE NUCLEUS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPIN LABELING; SUBCORTEX; VOXEL BASED MORPHOMETRY;

AGED; ARTIFACTS; BRAIN MAPPING; CEREBRAL ARTERIES; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; CLUSTER ANALYSIS; DATA INTERPRETATION, STATISTICAL; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PERFUSION; SPIN LABELS;

EID: 84855428685     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.10.033     Document Type: Article

References (57)

1. Amorim B.J., Camargo E.C., Etchebehere E.C. Regional CBF changes in Parkinson's disease: the importance of functional neuroimaging analyses. Eur. J. Nucl. Med. Mol. Imaging 2007, 34:1455-1457.
2. Ashburner J. A fast diffeomorphic image registration algorithm. NeuroImage 2007, 38:95-113.
3. Ashburner J., Friston K.J. Unified segmentation. NeuroImage 2005, 26:839-851.
4. Bates J.F., Goldman-Rakic P.S. Prefrontal connections of medial motor areas in the rhesus monkey. J. Comp. Neurol. 1993, 336:211-228.
5. Berding G., Odin P., Brooks D.J., Nikkhah G., Matthies C., Peschel T., Shing M., Kolbe H., van Den Hoff J., Fricke H., Dengler R., Samii M., Knapp W.H. Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET. Mov. Disord. 2001, 16:1014-1022.
6. Bohnen N.I., Minoshima S., Giordani B., Frey K.A., Kuhl D.E. Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia. Neurology 1999, 52:541-546.
7. Borghammer P., Jonsdottir K.Y., Cumming P., Ostergaard K., Vang K., Ashkanian M., Vafaee M., Iversen P., Gjedde A. Normalization in PET group comparison studies-the importance of a valid reference region. NeuroImage 2008, 40:529-540.
8. Borghammer P., Cumming P., Aanerud J., Forster S., Gjedde A. Subcortical elevation of metabolism in Parkinson's disease-a critical reappraisal in the context of global mean normalization. NeuroImage 2009, 47:1514-1521.
9. Borghammer P., Cumming P., Aanerud J., Gjedde A. Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson's disease. NeuroImage 2009, 45:249-257.
10. Borghammer P., Chakravarty M., Jonsdottir K.Y., Sato N., Matsuda H., Ito K., Arahata Y., Kato T., Gjedde A. Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages. Brain Struct. Funct. 2010, 214:303-317.
11. Borghammer P., Hansen S.B., Eggers C., Chakravarty M., Vang K., Aanerud J., Hilker R., Heiss W.D., Rodell A., Munk O.L., Keator D., Gjedde A. Glucose metabolism in small subcortical structures in Parkinson's disease. Acta Neurol. Scand. 2011, Jun 21, [Epub ahead of print]. 10.1111/j.1600-0404.2011.01556.x.
12. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
13. Burton E.J., McKeith I.G., Burn D.J., Williams E.D., O'Brien J.T. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004, 127:791-800.
14. Caballol N., Marti M.J., Tolosa E. Cognitive dysfunction and dementia in Parkinson disease. Mov. Disord. 2007, 22(Suppl 17):S358-S366.
15. Cassidy P.J., Radda G.K. Molecular imaging perspectives. J. R. Soc. Interface 2005, 2:133-144.
16. Detre J.A., Leigh J.S., Williams D.S., Koretsky A.P. Perfusion imaging. Magn. Reson. Med. 1992, 23:37-45.
17. Eckert T., Tang C., Eidelberg D. Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurol. 2007, 6:926-932.
18. Eickhoff S.B., Stephan K.E., Mohlberg H., Grefkes C., Fink G.R., Amunts K., Zilles K. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. NeuroImage 2005, 25:1325-1335.
19. Feinberg D.A., Ramanna S., Guenther M. Evaluation of New ASL 3D GRASE Sequences Using Parallel Imaging, Segmented and Interleaved k-space at 3T with 12- and 32-channel Coils 2009, 622. International Society of Magnetic Resonance in Medicine 17th Scientific Meeting, Hawaii.
20. Fernandez-Seara M.A., Edlow B.L., Hoang A., Wang J., Feinberg D.A., Detre J.A. Minimizing acquisition time of arterial spin labeling at 3T. Magn. Reson. Med. 2008, 59:1467-1471.
21. Fernandez-Seara M.A., Wang J., Feinberg D.A., Detre J.A. Achieving Late Inflow Delay in Pseudo-CASL 3D GRASE Using a Hybridized Labeling and Background Suppression Scheme 2008, 3343. International Society of Magnetic Resonance in Medicine 16th Scientific Meeting, Toronto (Canada.
22. Fernandez-Seara M., Aznarez-Sanado M., Loayza F., Villagra F., Pastor M. Hypoperfusion in Parkinson's disease assessed by arterial spin labeling perfusion MRI. J. Cereb. Blood Flow Metab. 2009, 29:S570-S572.
23. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
24. Grunder G. "Absolute" or "relative": choosing the right outcome measure in neuroimaging. NeuroImage 2009, 45:258-259.
25. Hayasaka S., Phan K.L., Liberzon I., Worsley K.J., Nichols T.E. Nonstationary cluster-size inference with random field and permutation methods. NeuroImage 2004, 22:676-687.
26. Hu M.T., Taylor-Robinson S.D., Chaudhuri K.R., Bell J.D., Labbe C., Cunningham V.J., Koepp M.J., Hammers A., Morris R.G., Turjanski N., Brooks D.J. Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study. Brain 2000, 123(Pt 2):340-352.
27. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
28. Kamagata K., Motoi Y., Hori M., Suzuki M., Nakanishi A., Shimoji K., Kyougoku S., Kuwatsuru R., Sasai K., Abe O., Mizuno Y., Aoki S., Hattori N. Posterior hypoperfusion in Parkinson's disease with and without dementia measured with arterial spin labeling MRI. J. Magn. Reson. Imaging 2011, 33:803-807.
29. Kikuchi A., Takeda A., Kimpara T., Nakagawa M., Kawashima R., Sugiura M., Kinomura S., Fukuda H., Chida K., Okita N., Takase S., Itoyama Y. Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease. J. Neurol. Sci. 2001, 193:29-36.
30. Kiyosawa M., Baron J.C., Hamel E., Pappata S., Duverger D., Riche D., Mazoyer B., Naquet R., MacKenzie E.T. Time course of effects of unilateral lesions of the nucleus basalis of Meynert on glucose utilization by the cerebral cortex. Positron tomography in baboons. Brain 1989, 112(Pt 2):435-455.
31. Lancaster J.L., Woldorff M.G., Parsons L.M., Liotti M., Freitas C.S., Rainey L., Kochunov P.V., Nickerson D., Mikiten S.A., Fox P.T. Automated Talairach atlas labels for functional brain mapping. Hum. Brain. Mapp. 2000, 10:120-131.
32. Liepelt I., Reimold M., Maetzler W., Godau J., Reischl G., Gaenslen A., Herbst H., Berg D. Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET. Mov. Disord. 2009, 24:1504-1511.
33. Lu M.T., Preston J.B., Strick P.L. Interconnections between the prefrontal cortex and the premotor areas in the frontal lobe. J. Comp. Neurol. 1994, 341:375-392.
34. Luppino G., Matelli M., Camarda R., Rizzolatti G. Corticocortical connections of area F3 (SMA-proper) and area F6 (pre-SMA) in the macaque monkey. J. Comp. Neurol. 1993, 338:114-140.
35. Ma Y., Tang C., Moeller J.R., Eidelberg D. Abnormal regional brain function in Parkinson's disease: truth or fiction?. NeuroImage 2009, 45:260-266.
36. Ma Y., Huang C., Dyke J.P., Pan H., Alsop D., Feigin A., Eidelberg D. Parkinson's disease spatial covariance pattern: noninvasive quantification with perfusion MRI. J. Cereb. Blood Flow Metab. 2010, 30:505-509.
37. MacDonald V., Halliday G.M. Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease. Mov. Disord. 2002, 17:1166-1173.
38. Maldjian J.A., Laurienti P.J., Kraft R.A., Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage 2003, 19:1233-1239.
39. Martinez-Martin P., Gil-Nagel A., Gracia L.M., Gomez J.B., Martinez-Sarries J., Bermejo F. Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group. Mov. Disord. 1994, 9:76-83.
40. Matelli M., Luppino G., Geyer S., Zilles K. Motor Cortex. The Human Nervous System 2004, 973-996. Elsevier Academic Press. G. Paxinos, J. Mai (Eds.).
41. Melzer T.R., Watts R., MacAskill M.R., Pearson J.F., Rueger S., Pitcher T.L., Livingston L., Graham C., Keenan R., Shankaranarayanan A., Alsop D.C., Dalrymple-Alford J.C., Anderson T.J. Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. Brain 2011, 134:845-855.
42. Mito Y., Yoshida K., Yabe I., Makino K., Hirotani M., Tashiro K., Kikuchi S., Sasaki H. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease. Clin. Neurol. Neurosurg. 2005, 107:396-403.
43. Obeso J.A., Marin C., Rodriguez-Oroz C., Blesa J., Benitez-Temino B., Mena-Segovia J., Rodriguez M., Olanow C.W. The basal ganglia in Parkinson's disease: current concepts and unexplained observations. Ann. Neurol. 2008, 64(Suppl 2):S30-S46.
44. Obeso J.A., Rodriguez-Oroz M.C., Goetz C.G., Marin C., Kordower J.H., Rodriguez M., Hirsch E.C., Farrer M., Schapira A.H., Halliday G. Missing pieces in the Parkinson's disease puzzle. Nat. Med. 2010, 16:653-661.
45. Petrides M., Pandya D. The Frontal Cortex. The Human Nervous System 2004, 950-972. Elsevier Academic Press. G. Paxinos, J. Mai (Eds.).
46. Picard N., Strick P.L. Imaging the premotor areas. Curr. Opin. Neurobiol. 2001, 11:663-672.
47. Possin K.L. Visual spatial cognition in neurodegenerative disease. Neurocase 2011, 16:466-487.
48. Poston K.L., Eidelberg D. Network biomarkers for the diagnosis and treatment of movement disorders. Neurobiol. Dis. 2009, 35:141-147.
49. Raichle M.E. Behind the scenes of functional brain imaging: a historical and physiological perspective. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:765-772.
50. Seeley W.W., Menon V., Schatzberg A.F., Keller J., Glover G.H., Kenna H., Reiss A.L., Greicius M.D. Dissociable intrinsic connectivity networks for salience processing and executive control. J. Neurosci. 2007, 27:2349-2356.
51. Shimada H., Hirano S., Shinotoh H., Aotsuka A., Sato K., Tanaka N., Ota T., Asahina M., Fukushi K., Kuwabara S., Hattori T., Suhara T., Irie T. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 2009, 73:273-278.
52. Tang C.C., Poston K.L., Dhawan V., Eidelberg D. Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J. Neurosci. 2010, 30:1049-1056.
53. Wang J., Zhang Y., Wolf R.L., Roc A.C., Alsop D.C., Detre J.A. Amplitude modulated continuous arterial spin labeling perfusion MR with single coil at 3.0 Tesla. Radiology 2005, 235:218-228.
54. Wang Z., Aguirre G.K., Rao H., Wang J., Fernandez-Seara M.A., Childress A.R., Detre J.A. Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magn. Reson. Imaging 2008, 26:261-269.
55. Williams, D.S., Detre, J.A., Leigh, J.S., Koretsky, A.P., 1992. Magnetic resonance imaging of perfusion using spin inversion of arterial water.[erratum appears in Proc. Natl. Acad. Sci. U S A 1992 May 1;89(9):4220]. Proc. Natl. Acad. Sci. U S A 89, 212-216.
56. Xu G., Rowley H.A., Wu G., Alsop D.C., Shankaranarayanan A., Dowling M., Christian B.T., Oakes T.R., Johnson S.C. Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer's disease. NMR Biomed. 2010, 23:286-293.
57. Zilles K., Schlaug G., Geyer S., Luppino G., Matelli M., Qu M., Schleicher A., Schormann T. Anatomy and transmitter receptors of the supplementary motor areas in the human and nonhuman primate brain. Supplementary Sensorimotor Area 1996, 70:29-43. Lippincott-Raven, Philadelphia. H.O. Lüders (Ed.).